Woodline Partners’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Buy |
290,943
+8,758
| +3% | +$19.2K | ﹤0.01% | 837 |
|
|
2025
Q1 | $384K | Sell |
282,185
-280,187
| -50% | -$381K | ﹤0.01% | 839 |
|
|
2024
Q4 | $748K | Buy |
562,372
+27,325
| +5% | +$36.3K | 0.01% | 795 |
|
|
2024
Q3 | $621K | Buy |
+535,047
| New | +$621K | 0.01% | 526 |
|
|
2023
Q2 | – | Sell |
-436,776
| Closed | -$791K | – | 633 |
|
|
2023
Q1 | $791K | Buy |
436,776
+237,445
| +119% | +$430K | 0.01% | 491 |
|
|
2022
Q4 | $530K | Sell |
199,331
-725,916
| -78% | -$1.93M | 0.01% | 596 |
|
|
2022
Q3 | $3.06M | Buy |
925,247
+175,209
| +23% | +$580K | 0.04% | 380 |
|
|
2022
Q2 | $2.73M | Sell |
750,038
-13,858
| -2% | -$50.4K | 0.04% | 382 |
|
|
2022
Q1 | $3.89M | Sell |
763,896
-74,130
| -9% | -$377K | 0.06% | 276 |
|
|
2021
Q4 | $6.39M | Buy |
838,026
+88,007
| +12% | +$671K | 0.09% | 253 |
|
|
2021
Q3 | $11.1M | Sell |
750,019
-41,566
| -5% | -$615K | 0.18% | 147 |
|
|
2021
Q2 | $14.6M | Buy |
+791,585
| New | +$14.6M | 0.27% | 98 |
|